To investigate the relationship between NAT10 expression and malignancy of GBM, we explored the mRNA levels of NAT10 in non-tumor brain regions and GBM tissues, as well as the survival time of patients with GBM, using GlioVis, data visualization tools for brain tumor datasets (22) (http://gliovis.bioinfo.cnio.es/). This evidence concerns the gene NAT10 and brain neoplasm.